相关实验视频

Updated: Jun 5, 2025

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

祖拉诺治疗产后抑郁症:两个随机研究的系统审查和元分析

Juliana Almeida Oliveira¹, Karine Eskandar², Marcos Aurélio Araújo Freitas³

¹Universidade Federal de Minas Gerais Belo HorizonteMG Brasil Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia

|December 13, 2024

概括

祖拉诺作为产后抑郁症 (PPD) 的有效口服治疗,有望改善抑郁症症状和缓解率. 虽然通常是安全的,但增加镇静风险需要进一步评估.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
药理学药理学是一个学科.

背景情况:

产后抑郁症 (PPD) 显著影响母亲的心理健康.
对于PPD,只有有限的口服治疗选择可供选择.
祖拉诺是一种用于治疗PPD的新型口服药物.

研究的目的:

为了评估与祖拉诺治疗的产后抑郁症妇女的母亲的结果.
评估与安慰剂相比,祖拉诺的有效性和安全性.

主要方法:

在2023年9月对PubMed,Embase和Cochrane试验进行系统搜索.
包括随机对照试验,比较祖拉诺和安慰剂.
使用审查经理5进行统计分析,使用Cochrane偏差风险工具进行质量评估.

主要成果:

包括两项涉及346名女性的研究,其中174名接受了祖兰.
祖拉诺显著改善了临床全球印象反应和汉密尔顿抑郁症评分尺度缓解在15天和45天.
祖拉诺还导致症状缓解和降低抗抑郁药剂量,并增加了镇静风险.

结论:

祖拉诺可能是一种安全有效的门诊治疗产后抑郁症.
需要进一步评估祖拉诺的镇静作用.
这种口服药物为PPD提供了一个新的治疗途径.

关键词:

大型抑郁症主要是抑郁症.产后抑郁症产后抑郁症合成的神经类固醇.祖兰诺龙 (Zuranolone) 是一种氨酸.

更多相关视频

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...